Results 231 to 240 of about 1,818,460 (375)
Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report. [PDF]
Chang YK+4 more
europepmc +1 more source
Abstract Background N‐acetyltransferase 10 (NAT10) was reported to be associated with the immune microenvironment in several cancers. However, it is not known in pancreatic ductal adenocarcinoma (PDAC). This study aimed to elucidate the roles and mechanisms of NAT10 in tumor malignancy and the tumor microenvironment (TME) in PDAC.
Enhong Chen+11 more
wiley +1 more source
Invasive ductal carcinoma at the site of a cosmetic nipple piercing. [PDF]
Bui J+6 more
europepmc +1 more source
CARCINOMAS OF THE GALLBLADDER AND THE BILE DUCT EACH DIAGNOSED PREOPERATIVELY IN EARLY STAGE
Kazumori KARAKI+2 more
openalex +2 more sources
The discovery of novel ligands recruiting less explored E3 ligases remains challenging. Herein, the discovery of a novel Mouse double minute 2‐recruiting Proteolysis‐Targeting Chimera is reported, which shows preferential degradation of the Bromodomain‐containing protein 4 short isoform (BRD4 S) and c‐Myc compared with MZ1, a validated Von‐Hippel ...
Mihaela P. Ficu+4 more
wiley +1 more source
Assessment of Human Epididymis Protein 4 Expression in Breast Ductal Carcinoma In Situ. [PDF]
Kim NI, Park MH, Lee JS.
europepmc +1 more source
Saikosaponin b1 attenuates liver fibrosis by competitively disrupting the interaction between signal transducer and activator of transcription 3 (STAT3) and glioma‐associated oncogene‐1 (Gli1) in the activated hepatic stellate cells (HSCs). The blocked interaction of STAT3 and Gli1 promotes the degradation of Gli1, inhibits Gli1 transcriptional ...
Meiyu Shao+15 more
wiley +1 more source
Anti-Cw in a Japanese patient with carcinoma of the bile duct.
Emiko Maruyama+3 more
openalex +2 more sources
ABSTRACT Background In recent years, particle therapy has shown promise as a local treatment for salivary gland carcinoma (SGC); however, its efficacy and safety remain unclear. This study aimed to evaluate the clinical outcomes of intensity‐modulated proton therapy (IMPT) for SGC.
Gaku Takano+16 more
wiley +1 more source